Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

237 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Equol: history, chemistry, and formation.
Setchell KD, Clerici C. Setchell KD, et al. Among authors: clerici c. J Nutr. 2010 Jul;140(7):1355S-62S. doi: 10.3945/jn.109.119776. Epub 2010 Jun 2. J Nutr. 2010. PMID: 20519412 Free PMC article. Review.
Equol: pharmacokinetics and biological actions.
Setchell KD, Clerici C. Setchell KD, et al. Among authors: clerici c. J Nutr. 2010 Jul;140(7):1363S-8S. doi: 10.3945/jn.109.119784. Epub 2010 Jun 2. J Nutr. 2010. PMID: 20519411 Free PMC article. Review.
S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.
Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, Heubi JE. Setchell KD, et al. Among authors: clerici c. Am J Clin Nutr. 2005 May;81(5):1072-9. doi: 10.1093/ajcn/81.5.1072. Am J Clin Nutr. 2005. PMID: 15883431 Clinical Trial.
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Clerici C, Castellani D, Asciutti S, Pellicciari R, Setchell KD, O'Connell NC, Sadeghpour B, Camaioni E, Fiorucci S, Renga B, Nardi E, Sabatino G, Clementi M, Giuliano V, Baldoni M, Orlandi S, Mazzocchi A, Morelli A, Morelli O. Clerici C, et al. Toxicol Appl Pharmacol. 2006 Jul 15;214(2):199-208. doi: 10.1016/j.taap.2005.12.017. Epub 2006 Feb 17. Toxicol Appl Pharmacol. 2006. PMID: 16487557
237 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page